Hem › Ulcerös kolit › Maryland
Kliniska studier för Ulcerös kolit i Maryland
13 studier för Ulcerös kolit söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 18 till 85 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07619547A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Capital Digestive Care, Chevy Chase
- Woodholme Gastroenterology, Glen Burnie
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 011, Glen Burnie
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07012395Immune Regulation in Ulcerative Colitis or Crohn s Disease
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
1 Day – 75 Years · Alla kön · Uppdaterad 28 sep. 2026 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Chevy Chase Clinical Research, Chevy Chase
- Woodholme Gastroenterology Associates, Glen Burnie
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Mercy Medical Center, Baltimore - Site Number: 8400117, Baltimore
- Mid-Atlantic GI Research, LLC - Site Number: 8400106, Greenbelt
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Mercy Medical Center, Baltimore
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase
- Woodholme Gastroenterology Associates PA, Glen Burnie
RekryterarObservationsstudie
Ålder 18 till 64 · Alla kön · Uppdaterad 9 juli 2026 · NCT06398626A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Woodholme Gastroenterology Associates, Glen Burnie
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 22 maj 2026 · NCT06764615Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Capital Digestive Care, Chevy Chase
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 8 maj 2025 · NCT06750731Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.